Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 8.25
-0.33 (-3.85%)
Sep 4, 2026, 5:07 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 65.5 million as of September 4, 2026. Its market cap has increased by 203.07% in one year.
Market Cap
65.50M
Enterprise Value
57.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.25
ChartMarket Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has increased from 53.75M to 65.50M, an increase of 21.87%. That is a compound annual growth rate of 3.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 65.50M | 134.88% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 118.19M |
| Bioventix | 90.13M |
| Faron Pharmaceuticals Oy | 80.14M |
| 4basebio | 73.81M |
| Ondine Biomedical | 62.35M |
| Sareum Holdings | 48.50M |
| hVIVO | 46.72M |
| Hemogenyx Pharmaceuticals | 38.42M |